Dogwood Therapeutics DWTX Treasury Stock
Treasury Stock at other companies
Other financials
Where this comes from
Reported directly by Dogwood Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:TreasuryStockCommonValue.
The official record: Dogwood Therapeutics’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dogwood Therapeutics's treasury stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Dogwood Therapeutics's treasury stock?
- Dogwood Therapeutics (DWTX) reported treasury stock of $299.13K in Q1 2026.
- How has Dogwood Therapeutics's treasury stock changed year-over-year?
- Dogwood Therapeutics's treasury stock decreased by 0.0% year-over-year, from $299.13K to $299.13K.
- What is the long-term trend for Dogwood Therapeutics's treasury stock?
- Over 2 years (2023 to 2025), Dogwood Therapeutics's treasury stock has grown at a 0.0% compound annual growth rate (CAGR), from $299.13K to $299.13K.
- What does treasury stock mean?
- Shares repurchased by the company and held in treasury, reducing equity. Recorded at cost and presented as a negative equity component.